IP Library Granted Patent US 9,827,412
Granted Patent B2
US 9,827,412 · App. 15/202,256 · Granted Nov 28, 2017

Systems and methods for treating shoulder pain related to subacromial impingement syndrome

Inventors: Maria E. Bennett (Beachwood, OH); Joseph W. Boggs, II (Chapel Hill, NC); John Chae (Strongsville, OH)
Assignee: SPR Therapeutics, LLC
A61N1/0504A61N1/025A61N1/0502A61N1/0551A61N1/08A61N1/36071A61N1/0456
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,827,412
App. No.
15/202,256
Granted
Nov 28, 2017
Kind
B2
Abstract

Systems and methods are provided for treating chronic pain occurring secondarily to subacromial impingement syndrome in a human body. A system is provided to deliver percutaneous electrical stimulation through at least one electrode to neurological motor points of the posterior and middle deltoid muscles to mediate such pain. One-time, continued and/or periodic dosing of treatment methods according to the present invention may result in a change to central nervous system maladaptive neuroplasticity.

Claims (29)

1. A method comprising the steps of:

placing an electrode in subepidermal tissue of a human; and

delivering electrical stimulation through the electrode,

wherein, after the delivering step, a level of pain perceived by the human, wherein the pain was caused by or occurring secondarily to subacromial impingement syndrome, is reduced.

2. A method according to claim 1 , wherein during the delivering step, a level of pain perceived by the human, wherein the pain was caused by or occurring secondarily to subacromial impingement syndrome, is reduced.

3. A method comprising the steps of:

percutaneously inserting or instructing percutaneous insertion of a lead into a patient, the lead having an electrode wherein the electrode is positionable in subepidermal tissue of the patient;

delivering or instructing delivery of electrical stimulation through the electrode altering maladaptive neuroplasticity in a central nervous system of the patient; and

reducing or eliminating chronic pain of the patient.

4. The method of claim 3 , wherein the lead is attached with the electrode.

5. The method of claim 3 , wherein the electrode is formed as part of the lead.

6. The method of claim 3 , wherein the lead includes a portion having an insulated body and the electrode is formed from a portion of the lead free of the insulated body.

7. The method of claim 3 further comprising producing or instructing production of a muscle contraction in a target area.

8. A method comprising the steps of:

percutaneously inserting or instructing percutaneous insertion of a lead into a patient;

placing or instructing placement of an electrode in subepidermal tissue of the patient, the electrode operatively coupled with the lead;

delivering or instructing delivery of electrical stimulation through the electrode to generate a muscle contraction in a target area;

reducing or instructing reduction of central hypersensitivity in the patient; and

producing or instructing production of a therapeutic effect of reducing chronic pain in the patient.

9. A method comprising the steps of:

percutaneously inserting or instructing percutaneous insertion of a lead into a patient;

placing or instructing placement of an electrode in subepidermal tissue of the patient, the electrode operatively coupled with the lead;

delivering or instructing delivery of electrical stimulation through the electrode to generate a muscle contraction in a target area; and

sustaining or instructing sustaining of functional reorganization of maladaptive neuroplastic changes of a nervous system of the patient associated with chronic pain.

10. A method comprising the steps of:

percutaneously inserting or instructing percutaneous insertion of a lead into a tissue of a human; and

delivering or instructing delivery of stimulation through at least one electrode operatively coupled with the lead to a neurological motor point of the human;

generating or instructing generation of a muscle contraction in a target area; and

changing or instructing change of central nervous system maladaptive neuroplasticity of the human producing a therapeutic effect to reduce chronic pain.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Feb 8, 2024
From: THE DIRECTOR OF DEVELOPMENT, STATE OF OHIO, FORMERLY KNOWN AS THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC., FORMERLY KNOWN AS SPR THERAPEUTICS, LLC
Reel/Frame 066526/0025 →
SECURITY INTEREST Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: GEMINO HEALTHCARE FINANCE, LLC
Reel/Frame 066412/0400 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: SLR INVESTMENT CORP., AS AGENT
Reel/Frame 066381/0075 →
RELEASE OF SECURITY INTEREST Recorded Oct 15, 2019
From: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC.
Reel/Frame 050728/0676 →
RELEASE OF SECURITY INTEREST Recorded Oct 15, 2019
From: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC.
Reel/Frame 050728/0721 →
CHANGE OF NAME Recorded Dec 6, 2017
From: SPR THERAPEUTICS, LLC
To: SPR THERAPEUTICS, INC.
Reel/Frame 044716/0812 →
SECURITY INTEREST Recorded Nov 9, 2017
From: SPR THERAPEUTICS, INC.
To: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
Reel/Frame 044414/0575 →
SECURITY INTEREST Recorded Nov 9, 2017
From: SPR THERAPEUTICS, INC.
To: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
Reel/Frame 044715/0395 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 5, 2016
From: BENNETT, MARIA E; BOGGS, JOSEPH W., II; CHAE, JOHN
To: SPR THERAPEUTICS, LLC
Reel/Frame 039076/0739 →
Continuity (5)
Continuation 14536951 · Nov 10, 2014
Continuation 13991033
Provisional Application 61419537 · Dec 3, 2010
Provisional Application 61540934 · Sep 29, 2011
Related Publication 20170056645A1 · Mar 2, 2017